The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global generic oncology drugs market size to reach a value of US$ 36.9 Billion by 2027.
The rising prevalence of cancer due to the rapid increase in the number of smokers, sedentary lifestyles and excessive exposure to ultraviolet (UV) rays, represents one of the key drivers for the global generic oncology drugs market.
Several initiatives undertaken by the governments of various countries to promote generic drugs and reduce healthcare expenses related to cancer treatment is one of the key trends in the global generic oncology drugs market.
Sudden outbreak of the COVID-19 pandemic has led to an increase in the demand for generic oncology drugs as these are being repurposed as a potential treatment option. This, in turn, has positively influenced the global market growth.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at